A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients

Published:2011-09 Issue:3 Volume:186 Page:882-888
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Womble Paul R.¹,VanVeldhuizen Peter J.²,Nisbet Alan A.¹,Reed Greg A.³,Thrasher J. Brantley¹,Holzbeierlein Jeffrey M.¹

Affiliation:

1. Department of Urology, University of Kansas Hospital, Kansas City, Kansas

2. Department of Internal Medicine, Division of Hematology/Oncology, University of Kansas Hospital, Kansas City, Kansas

3. Department of Pharmacology, University of Kansas Hospital, Kansas City, Kansas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference25 articles.

1. Biochemical outcome after radical prostatectomy, radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

2. Markers and meaning of primary treatment failure;Swindle;Urol Clin North Am,2003

3. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer;D'Amico;J Clin Oncol,1999

4. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer;D'Amico;J Urol,1998

5. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway;Cancer Cell International;2021-08-17

2. Metformin: current clinical applications in nondiabetic patients with cancer;Aging;2020-02-18

3. Neoadjuvant Approaches Prior To Radical Prostatectomy;The Cancer Journal;2020-01

4. NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE;Cancer Urology;2018-10-02

5. Surgical management of prostate cancer;Evidence-Based Urology;2018-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3